Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
Transcat acquired Southeastern Biomedical Associates for $12.8 million in cash, expanding its accredited biomedical calibration and repair capabilities throughout the southeastern United States. The acquisition supports Transcat's strategy to scale in regulated life science end markets and is expected to contribute to its fiscal 2027 growth and margin expansion targets.
Key figures
- Deal Value Usd
- 12800000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.